Turning Point Therapeutics (TPTX) stock Forecast for 2022 – 2026

Turning Point Therapeutics (TPTX) stock Forecast for 2022 – 2026

Last update: December 8, 2022 (12:33)

Sector: Healthcare

The share price of Turning Point Therapeutics, Inc. (TPTX) now

What analysts predict: $
52-week high/low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the average price over the previous 50/200 days. For Turning Point Therapeutics stocks, the 50-day moving average is the support level today.

For Turning Point Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Turning Point Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Turning Point Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Turning Point Therapeutics share be worth in 2023 - 2027?

When should I take profit in Turning Point Therapeutics stock? When should I record a loss on Turning Point Therapeutics stock? What are analysts' forecasts for Turning Point Therapeutics stock? What is the future of Turning Point Therapeutics stock? We forecast Turning Point Therapeutics stock performance using neural networks based on historical data on Turning Point Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Turning Point Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Turning Point Therapeutics shares. This happens once a day.




Historical and forecast chart of Turning Point Therapeutics stock

The chart below shows the historical price of Turning Point Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Turning Point Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Turning Point Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 10 80.36 79.01 82.96 5.00
Dec 11 81.13 79.28 84.39 6.45
Dec 12 81.52 79.46 83.82 5.48
Dec 13 77.65 76.21 80.50 5.62
Dec 14 81.71 78.62 84.31 7.23
Dec 15 81.90 78.27 85.20 8.85
Dec 16 82.59 79.82 84.18 5.46
Dec 17 83.63 80.37 86.29 7.37
Dec 18 83.18 82.18 84.58 2.91
Dec 19 82.13 79.27 84.65 6.78
Dec 20 83.56 80.15 85.37 6.51
Dec 21 88.12 85.69 91.67 6.97
Dec 22 88.39 85.47 91.20 6.70
Dec 23 86.27 82.18 89.11 8.44
Dec 24 87.51 86.41 88.93 2.92
Dec 25 88.09 85.76 89.62 4.50
Dec 26 91.68 89.48 93.61 4.61
Dec 27 96.36 91.73 100.46 9.52
Dec 28 93.47 90.10 96.38 6.97
Dec 29 95.71 91.75 99.67 8.64
Dec 30 95.42 92.16 98.23 6.59
Dec 31 89.81 86.20 92.99 7.88
Jan 01 93.96 90.35 95.93 6.18
Jan 02 98.25 95.12 99.78 4.90
Jan 03 104.02 102.46 107.21 4.63
Jan 04 102.90 99.94 105.62 5.68
Jan 05 105.49 101.06 110.49 9.33
Jan 06 99.73 94.94 102.60 8.07
Jan 07 95.54 92.91 98.35 5.86
Jan 08 98.24 94.11 100.89 7.20

Turning Point Therapeutics Daily Price Targets


Turning Point Therapeutics Stock Forecast 12-10-2022.

Forecast target price for 12-10-2022: $80.36.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 4.766%.
Pessimistic target level: 79.01
Optimistic target level: 82.96

Turning Point Therapeutics Stock Forecast 12-11-2022.

Forecast target price for 12-11-2022: $81.13.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.057%.
Pessimistic target level: 79.28
Optimistic target level: 84.39

Turning Point Therapeutics Stock Forecast 12-12-2022.

Forecast target price for 12-12-2022: $81.52.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.194%.
Pessimistic target level: 79.46
Optimistic target level: 83.82

Turning Point Therapeutics Stock Forecast 12-13-2022.

Forecast target price for 12-13-2022: $77.65.
Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.325%.
Pessimistic target level: 76.21
Optimistic target level: 80.50

Turning Point Therapeutics Stock Forecast 12-14-2022.

Forecast target price for 12-14-2022: $81.71.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.746%.
Pessimistic target level: 78.62
Optimistic target level: 84.31

Turning Point Therapeutics Stock Forecast 12-15-2022.

Forecast target price for 12-15-2022: $81.90.
Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 8.133%.
Pessimistic target level: 78.27
Optimistic target level: 85.20

TPTX (TPTX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan. 81.53 69.87 85.47 18.26
Feb. 81.35 75.44 86.00 12.28
Mar. 82.42 75.71 87.68 13.65
Apr. 76.98 65.47 82.57 20.72
May. 81.56 69.18 95.01 27.19
Jun. 73.12 63.95 78.43 18.46
Jul. 81.01 76.02 91.70 17.10
Aug. 83.32 77.64 90.10 13.83
Sep. 75.26 66.98 83.53 19.82
Oct. 89.50 81.82 97.37 15.97
Nov. 93.43 77.19 98.57 21.69
Dec. 96.72 89.06 103.32 13.80

Turning Point Therapeutics forecast for this year


Turning Point Therapeutics Stock Prediction for Jan 2023

An uptrend is forecast for this month with an optimal target price of $81.5283. Pessimistic: $69.87. Optimistic: $85.47


Turning Point Therapeutics Stock Prediction for Feb 2023

An downtrend is forecast for this month with an optimal target price of $81.349. Pessimistic: $75.44. Optimistic: $86.00


Turning Point Therapeutics Stock Prediction for Mar 2023

An uptrend is forecast for this month with an optimal target price of $82.4228. Pessimistic: $75.71. Optimistic: $87.68


Turning Point Therapeutics Stock Prediction for Apr 2023

An downtrend is forecast for this month with an optimal target price of $76.9829. Pessimistic: $65.47. Optimistic: $82.57


Turning Point Therapeutics Stock Prediction for May 2023

An uptrend is forecast for this month with an optimal target price of $81.5556. Pessimistic: $69.18. Optimistic: $95.01


Turning Point Therapeutics Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $73.1228. Pessimistic: $63.95. Optimistic: $78.43


Turning Point Therapeutics Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $81.0054. Pessimistic: $76.02. Optimistic: $91.70


Turning Point Therapeutics Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $83.3222. Pessimistic: $77.64. Optimistic: $90.10


Turning Point Therapeutics Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $75.2566. Pessimistic: $66.98. Optimistic: $83.53


Turning Point Therapeutics Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $89.4951. Pessimistic: $81.82. Optimistic: $97.37


Turning Point Therapeutics Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $93.4329. Pessimistic: $77.19. Optimistic: $98.57


Turning Point Therapeutics Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $96.7218. Pessimistic: $89.06. Optimistic: $103.32



Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 99.06 86.86 116.06 25.16
Feb 113.45 94.73 118.94 20.35
Mar 136.16 119.38 157.13 24.02
Apr 139.75 119.15 162.51 26.68
May 125.92 114.01 148.08 23.01
Jun 123.98 108.43 140.62 22.89
Jul 128.62 119.28 146.44 18.55
Aug 122.67 104.05 143.18 27.33
Sep 117.01 104.39 135.80 23.13
Oct 107.22 101.09 124.68 18.92
Nov 113.83 98.05 124.85 21.46
Dec 118.84 98.44 139.23 29.29

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 123.28 101.58 137.39 26.06
Feb 136.03 113.58 149.80 24.17
Mar 153.09 137.26 177.00 22.45
Apr 163.19 144.88 170.73 15.14
May 156.01 142.63 169.05 15.63
Jun 134.04 127.26 154.98 17.89
Jul 137.29 117.66 161.15 26.99
Aug 149.07 124.80 169.07 26.19
Sep 137.92 119.71 146.41 18.24
Oct 125.17 118.01 146.38 19.38
Nov 120.22 106.46 131.59 19.09
Dec 129.21 110.73 143.99 23.10

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 127.79 115.14 141.00 18.34
Feb 131.72 120.71 146.79 17.77
Mar 148.82 123.94 166.17 25.42
Apr 121.32 113.31 131.19 13.63
May 109.58 104.75 123.08 14.89
Jun 119.70 107.59 133.92 19.66
Jul 113.91 103.63 121.43 14.65
Aug 104.38 98.64 112.88 12.61
Sep 105.53 100.43 118.53 15.28
Oct 100.89 85.35 105.99 19.47
Nov 101.56 91.05 119.21 23.62
Dec 108.93 101.98 119.71 14.81

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 107.97 92.53 113.67 18.60
Feb 122.46 101.18 131.89 23.29
Mar 132.16 125.47 150.47 16.62
Apr 135.65 117.74 142.81 17.55
May 140.12 127.48 162.32 21.46
Jun 130.26 113.64 149.74 24.11
Jul 101.60 87.97 117.25 24.97
Aug 95.34 79.61 106.04 24.92
Sep 104.15 85.82 116.98 26.64
Oct 119.28 110.62 124.79 11.36
Nov 119.80 105.30 131.66 20.02
Dec 129.82 108.11 148.09 27.00

Turning Point Therapeutics information and performance

Turning Point Therapeutics, Inc., a clinical stage biopharmaceutical company, designs and develops new small molecule targeted cancer therapies. He is developing a suite of tyrosine kinase inhibitors (TKIs) that targets cancer genetic factors in previously TKI-naive and TKI-treated patients.

Turning Point Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.